Title : Comparison of the Antiplatelet Effects of Once and Twice Daily Low-Dose Ticagrelor and Clopidogrel After Percutaneous Coronary Intervention.

Pub. Date : 2017 Jul 15

PMID : 28554486






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In conclusion, low-dose ticagrelor treatment, either with 90 mg QD or 45 mg BID, was associated with a more potent antiplatelet effect compared with clopidogrel treatment and once daily dose provided similar antiplatelet effect but favorable effect on optimal platelet inhibition compared with twice daily dose. Ticagrelor BH3 interacting domain death agonist Homo sapiens